News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
Rigel takes over Pfizer's Veppanu after Arvinas partnership ends
First-in-class protein degrader drug gets new owner months after approval, settling questions about its commercial future.
Pfizer dumps $1B breast cancer drug for $35M
Pharma giant sells rights to recently approved ARV-471 to Rigel Pharmaceuticals after massive writedown on oncology bet.
Isomorphic Labs raises $2.1B in second-largest biotech round
Alphabet's drug discovery unit closed a massive Series B, marking the second-largest private biotech fundraise in history.
Healthcare AI reporting needs incentive scrutiny, says journalist
A journalism fellowship reminder that AI healthcare coverage requires examining who benefits from the narrative being pushed.
Iran war hits pharma supply chains through energy costs
Three months into conflict, raw materials and shipping disruptions reach pharmaceutical manufacturers despite minimal Middle East production.
FDA Commissioner Makary resigns after days of uncertainty
The FDA chief's departure comes amid unclear circumstances, with limited details on the timing or reasons behind the decision.
Caidya books ASCO booth for oncology trial recruitment pitch
Clinical research company Caidya will exhibit at ASCO 2026 to showcase oncology study solutions focused on recruitment and regulatory compliance.
Fierce Biotech publishes sponsored whitepaper on CRM integration
Industry publication runs vendor-sponsored content on AI-powered customer relationship management for pharmaceutical companies.
Medication intelligence white paper pushes AI trust frameworks
Fierce Biotech publishes sponsored content on AI-driven clinical decision support without disclosing funding sources or methodology.
Med professor proposes federal AI doctor licensing after Utah debacle
Penn researcher calls for national competency standards and federal oversight after Utah suspended AI prescription program mid-deployment.
Psychiatrist warns of cognitive dependence patterns in AI use
Addiction medicine specialist identifies early warning signs when AI becomes the primary method for managing cognitive discomfort, not just a helpful tool.
New sepsis AI tools face adoption hurdles despite Epic's failure
Five years after Epic's sepsis algorithm flopped in hospitals, new models from startups and Epic itself still confront non-technical barriers to adoption.